{"name":"Parkinson's Disease and Movement Disorder Center of Boca Raton","slug":"parkinson-s-disease-and-movement-disorder-center-of-boca-raton","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNVGRVMmEybW9pazVwR2liYU9LWnFMOWI4VGxPa3pvRElrbWFLcXBpVE9feUxlZzd3SXNmVVIwU2ZKNGd1LUR2cnROS1ZyUjVEcDI0cXhLTW1VcUh4allMcmdBOUVuekowTWQtUS1qei0tMTEwR3NsUFhPN3lMcHlsSENYbEFJVzVlQVBPbFkxX0I0c05hSlVyUmtrMXkxZw?oc=5","date":"2025-10-08","type":"pipeline","source":"BioWorld News","summary":"Cala’s KIQ neuromodulating watch reduces essential tremor - BioWorld News","headline":"Cala’s KIQ neuromodulating watch reduces essential tremor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOeTB0Q25naTV0QlFuWkhKSTFvb3hDZ3JIakZfdXNld014Qzl5UGxKUmhYbUVIQ2FYYzBua1ZHbzhoVGhfZ01ybG9qZ0RqbE4wb2RXT1JHenBzOUZvM2lXVmtoTVhKUS1pWUJObm1HcXhYdFZyRkVZMVBla2NaME1VNVlXWk1rREJKemo1dFlsZnlwYzJpOGhHRzZpSlBRM1kxSFFz?oc=5","date":"2025-10-05","type":"trial","source":"NeurologyLive","summary":"Real-World EU Data Suggest Safety of High-Dose Apomorphine Infusion in Parkinson Disease - NeurologyLive","headline":"Real-World EU Data Suggest Safety of High-Dose Apomorphine Infusion in Parkinson Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNNkhhLVNkXzNudmhDbjJHUjhGVkFFWWEwMHloaUxaQnpoUUxhTVVHYXFtNzdybHVtQUpXMTctVlNtdHdlZzFmMWdDR0kyaVFHbUt3MUhsR1FHQUxJY1FlQXZ6bXQwYkJEeGdfVzJDSVN3Rk5FZHFlYUdqeVRDX0hhUjJ0RGdfdkpValhIMlFfLWtGX2s?oc=5","date":"2025-07-23","type":"pipeline","source":"Prevention","summary":"The Parkinson's Disease Treatments That May Be on the Horizon - Prevention","headline":"The Parkinson's Disease Treatments That May Be on the Horizon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFA0ZkY0RkFkOFYzaERIV0lIY05ITTFFdENjQXNJTXAteDI2LV82UGZtZ1dmamNCcVhoRzQydEZfVVRPanRsZUNRbkJfQ0RCOFMxVlc4eTVXeDNPbUNZYzEw?oc=5","date":"2025-07-01","type":"trial","source":"nature.com","summary":"Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials - nature.com","headline":"Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqbFdHWVQ3bGJMTnN0cXVvM1hVX0xmMGExNWw0U0xlZ3o3X3oxU1QwTzN6YWNGZGdPWW9MMUN5U1hfV0pHc3Bidi1CRFBrR19TWWxXVklKRWJfQm0zLWVV?oc=5","date":"2025-06-16","type":"pipeline","source":"nature.com","summary":"Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab | npj Digital Medicine - nature.com","headline":"Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxOWUtUUDhNRHdlOHlUd0ZfbGFqRWZHZGEtWVVDaG8wYklpdEFIajdpZllPbGtmQnczeUtlVFNneHBYRGZsS0xId0xKRC1RQzlSMFpCdFlFT3FtdWtGMU9pcndld3FYNXNoUXlMSFNuZUVvMXp5eXlMUmZOazVLQld2VVM1NWd0OGRmRFpCQ21aTkdDRWtZN0RQeGlyMFU3anV1emp3WTg0TGZxNDJWY2g1SW9zemdwbEc1NGFzZjB0ZjVXb19vbmNKNDRObkdVOFgtcUticFAzVTJqTHc5emd4S2NWRVowZ05TWUxMQ19PaGVOQTZNd09vbHhLdDB6SEo4SlU3Q0tXYWhCak5iUlhUM3JmRVRoUnl2LWl2NzdJNlAzRnc1NjMybDdxVXdnb1M0b2c?oc=5","date":"2025-05-29","type":"trial","source":"PR Newswire","summary":"Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor - PR Newswire","headline":"Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQV01RU0M4UEVjaXd1dUJnSGp2TzE1eUptY2ZJZThpNURqYjhfOUF1enpDSXl6MFNBUmx3OHdCb3FkaTY0OU1NV2xuNFA1TmU3Mi1VSkFHbmc2WWRvUlJXVUt1QnZxSmpvVDQ1M2JOQXE4bFlRb0xhUUFTZGh6U1NjR3hhdHJwZ283OTVYRUcxM25jbnAtVjVudVE5OUItQ0JuaU1zb2ZLQ0dURHpoOHNHZEc5UWJBQTFNNzUtSVluZnVhUU1vMGxhRGxSM3JkZGJweUFMS2RjVWdRWXQ3?oc=5","date":"2025-05-26","type":"pipeline","source":"U.S. Medicine","summary":"Debilitating Motor Fluctuations End Up Affecting All Parkinson’s Disease Patients - U.S. Medicine","headline":"Debilitating Motor Fluctuations End Up Affecting All Parkinson’s Disease Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNT3A3XzgwVVAwTnVfd0tJQmQ5b3N4V0VERHF6SDNGa3lnaWRjVXRfUFBick1fd0pUd2JHeDNTcEV0enRXdDNWMVJTUXlhaUJHbzJWWHh4XzlZWXdnWWMxS01aakUycFdRMk1mcHdZSkJFbzQ5M3U0WUhyMG1fS1h3TnRpdDc2bmpqeXZ5TVlQeXYtQXZCd3B1VThzX2t3am9BMHh4d20zNFJQLVhVUmxHeFNDU05BUllVbS0tSG5B?oc=5","date":"2025-02-07","type":"regulatory","source":"Pharmaceutical Executive","summary":"FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease - Pharmaceutical Executive","headline":"FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9yaHRtUktUS3B1VF9sUGZOQnVuQmVyaGxfSjJPd05FX3FHRHd6ekdWZU5FaUdWVWQ0YWRkRWVkQWxKeGZjdDh2M1JJOS1iWlJ1bWM1UmQzQmVZQWVtZmdZSUp1ZGhCS1pORUItNjkwZjU?oc=5","date":"2025-02-04","type":"regulatory","source":"MedPage Today","summary":"FDA OKs New Wearable Treatment for Parkinson's Disease - MedPage Today","headline":"FDA OKs New Wearable Treatment for Parkinson's Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPbzEzLW9QTDlaNUx4UVJRNmNwUG1VandqTXZSdVdHbEN4SFcwMHdNc3JIYmc0NkR1ajJ1LUM1QU45WkNVLUVUaHBBaEhkMXBVdjZJcHFETDBOTVBrQkhSVERNUkRLYmR6Z0FJU08zaU40QkRESDhJZk1qSUdiXzhPM1gxa1NNUk80SmdscTlfTThKWWk4bG1HNEw2T0RlckZfZS03OXI4UElLUFZuRU9YdXQydw?oc=5","date":"2025-02-04","type":"regulatory","source":"Drug Topics","summary":"FDA Approves Apomorphine for Treatment of Motor Fluctuations in Parkinson Disease - Drug Topics","headline":"FDA Approves Apomorphine for Treatment of Motor Fluctuations in Parkinson Disease","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1hNm1jVFNCMklwUVNOaDdkaDBHYWgxcTdFbDUyN2lzWXJzV3Itd1BVZTVfTV9TZkUwYWJDY2VRV1RzRVlfZnNXeDVLaDZZMVh5Y3BXTTdPMmVNdm84eVQzczBvb1MweHlnQkFLNzR2TW9CUQ?oc=5","date":"2023-10-21","type":"pipeline","source":"Psychiatrist.com","summary":"Effective Treatment Strategies for Motor and Nonmotor Symptoms of Parkinson Disease - Psychiatrist.com","headline":"Effective Treatment Strategies for Motor and Nonmotor Symptoms of Parkinson Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNMFdLZ2tESFFqRktjSmVaaHhBaUpkTjd4UmhqS214N19wQTUtdnktR3dJV2JsOGhzOE1taU9XcmUwMkpzVzZNOXdVbTRVYWhhODZvZ0kzYmRuemdJUXRkbjZKemJIU2swOEdLUkRPaVphekxFSFYzMTIwVXZOTzZKNEFRNlB0MTFSMDBSV1ptOWplWjdlR2RINWlQYnowZw?oc=5","date":"2023-04-26","type":"pipeline","source":"Parkinson's News Today","summary":"AAN 2023: Apomorphine infusion pump SPN-830 reduces ‘off’ time |... - Parkinson's News Today","headline":"AAN 2023: Apomorphine infusion pump SPN-830 reduces ‘off’ time |... - Parkinson's News Today","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}